EC Gastroenterology and Digestive System

This review is not intended to determine which is the best procedure, surgical or medical, in two of the most frequent surgeries in gastroenterology, but rather the objective is to assist in the improvement of the microbiome, in order to avoid the processes added morbidities, as well as determining some pre-, trans- or postoperative management that helps patients who have suffered one of these two conditions.

It is known that the impact that alterations of the gut microbiota (Dysbiosis-dysbacteriosis) or vice versa, generate inflammatory processes in other areas, some more intense than others, but all of them produce minimal, regular or maximum damage. Thus, we see that cholelithiasis can appear in inflammatory bowel disease, both in the gallbladder and in the bile duct and intrahepatic.

We will evaluate in unison the two processes cholecystectomy and appendectomy, and the changes in the various phyla that these produce, giving rise to probable parallel treatments.

In principle, we must understand the impact generated by more than nine million genes and accept that microorganisms, for the most part, are not our enemies, rather our allies, in a very interesting pairing (symbiosis), which we must care for and protect, since that this action fundamentally translates health.

We consider the use of biotics in both processes and point out the care that must be taken with these products, since some of them can also cause complications, as well as knowing which would be the best biotic and considering that they are foreign bodies, which do not they necessarily impact the digestive tract, as one would like.

We conclude with the consideration of how useful or not, the gut microbiota transplant could be and, everything that is missing, so that this methodology has a space for action.

 Keywords: Cholecystectomy (COL); Appendicectomy (AP); Gut Microbiota (GM); Microbiome (M); Intestinal Dysbiosis (ID)

1. Coldrey E. “Treatment of acute appendicitis”. British Medical Journal 5007 (1956): 1458-1461.
2. Moreno MC., et al. “Microbioma humano”. Revista De la Facultad de Medicina de la UNAM 6 (2018): 7-19.
3. Jiang X., et al. “Cholecystectomy promotes the development of colorectal cancer by the alternation of bile acid metabolism and the gut microbiota”. Frontiers in Medicine (Lausanne) 9 (2022): 1000563.
4. Aguilar Salinas P and Domínguez Garibaldi FJ. “Acute appendicitis in adults. Review”. Ciencia UG3 (2012): 21-28.
5. Molinero N., et al. “The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile”. Microbiome1 (2019): 100.
6. Watanabe S., et al. “Bile collected from the normal gallbladder of patients during surgery has simple bacterial flora”. Cureus 6 (2022): e25681.
7. Oh SJ., et al. “Acute appendicitis is associated with appendiceal microbiome changes including elevated Campylobacter jejuni levels”. BMJ Open Gastroenterology 1 (2020): e000412.
8. Guinane CM., et al. “Microbial composition of human appendices from patients following appendectomy”. mBio1 (2013): e00366-12.
9. Dan WY., et al. “Gastrointestinal microbiome and cholelithiasis: Current status and perspectives”. World Journal of Gastroenterology 10 (2023): 1589-1601.
10. Wang W., et al. “Cholecystectomy damages aging-associated intestinal microbiota construction”. Frontiers in Microbiology 9 (2018): 1402.
11. Jones MW., et al. “Acute cholecystitis”. National Library of Medicine (2023).
12. Blohs M., et al. “Acute appendicitis manifests as two microbiome state types with oral pathogens influencing severity”. Gut Microbes1 (2023): 2145845.
13. Chen J., et al. “The gallbladder and vermiform appendix influence the assemblage of intestinal microorganisms”. Future Microbiology 15 (2020): 541-555.
14. Quaglio AEV., et al. “Gut microbiota, inflammatory bowel disease and colorectal cancer”. World Journal of Gastroenterology 30 (2022): 4053-4060.
15. Sánchez-Alcoholado L., et al. “Incidental prophylactic appendectomy is associated with a profound microbial dysbiosis in the long-term”. Microorganisms 4 (2020): 609.
16. Cai S., et al. “Appendicectomy is associated with alteration of human gut bacterial and fungi communities”. Frontiers in Microbiology 12 (2021): 724980.
17. Shi F., et al. “Altered gut microbiome composition by appendectomy contributes to colorectal cancer”. Oncogene 42 (2023): 530-540.
18. Elwan TH., et al. “Unveiling the role of inflammatory mediators and gut microbiome in appendicitis: types and applications in clinical scoring”. Advanced Gut & Microbiome Research (2023): 1080495.
19. Wang D., et al. “Comparison of the effects of acute appendicitis and chronic cholecystitis on intestinal mucosal function during surgery”. Cureus 11 (2022): e30953.
20. Wu HJ and Wu E. “The role of gut microbiota in immune homeostasis and autoimmunity”. Gut Microbes1 (2012): 4-14.
21. Vitetta L., et al. “The vermiform appendix: an immunological organ Sustaining a microbiome inoculum”. Clinical Science (London)1 (2019): 1-8.
22. Asenjo BDA. “Comportamiento de ciertos parámetros inmunológicos, marcadores tumorales y eritropoyetina en colecistitis aguda y cáncer colorectal”. Tesis. Universidad Valladolid, España (1997).
23. Li F., et al. “Immunological effects of laparoscopic and open cholecystectomy”. Journal of International Medical Research 6 (2010): 2077-2083.
24. YJ Boo., et al. “Systemic immune response after open versus laparoscopic cholecystectomy in acute cholecystitis: A prospective randomized study”. Scandinavian Journal of Clinical and Laboratory Investigation2 (2007): 207-214.
25. Simon P., et al. “Inflammatory response is no different in children randomized to laparoscopic or open appendectomy”. Journal of Laparoendoscopy and Advances Surgical Techniquess1 (2009): 16.
26. Sanders NL., et al. “Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology”. World Journal of Gastroenterology 34 (2013): 5607-5614.
27. Potts JR 3^rd. “What are the indications for cholecystectomy?” Cleveland Clinic Journal of Medicine 1 (1990): 40-47.
28. Nguyen A and Lotfollahzadeh S. “Appendectomy”. National Library of Medicine. (NIH). National Center for biotechnology Information (2023).
29. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment for appendicitis (2021).
30. Collard M., et al. “Antibiotics alone as an alternative to appendectomy for uncomplicated acute appendicitis in adults: Changes in treatment modalities related to the COVID-19 health crisis”. Journal of Visceral Surgery 3S1 (2020): S33-S42.
31. Wang Q., et al. “Dysbiosis of gut microbiota after cholecystectomy is associated with non-alcoholic fatty liver disease in mice”. FEBS Open Bio 8 (2021): 2329-2339.
32. Choi SJ., et al. “Association of microbial dysbiosis with gallbladder diseases identified by bile microbiome profiling”. Journal of Korean Medical Science 28 (2021): e189.
33. Xu F., et al. “Cholecystectomy significantly alters gut microbiota homeostasis and metabolic profiles: a cross-sectional study”. Nutrients20 (2023): 4399.
34. Nakahara K., et al. “Gut microbiota of Parkinson’s disease in an appendectomy cohort: a preliminary study”. Scientific Reports 1 (2023): 2210.
35. Babakhanov AT., et al. “Impact of appendectomy on gut microbiota”. Surgical Infections (Larchmt)7 (2021): 651-661.
36. Maldonado Galdeano C., et al. “Stimulation of innate immune cells induced by probiotics: participation of toll-like receptors”. Journal of Clinical and Cellular Immunology 1 (2015): 1000283.
37. Petruzziello C., et al. “Probiotics, the immune response and acute appendicitis: a review”. Vaccines (Basel)7 (2023): 1170.
38. Han ML., et al. “Probiotics for gallstone prevention in patients with bariatric surgery: A prospective randomized trial”. Asian Journal of Surgery12 (2022): 2664-2669.
39. J Liu., et al. “Acute cholecystitis associated with infection of Enterobacteriaceae from gut microbiota”. Clinical Microbiology and Infection9 (2015): 851.e1-851.e9.
40. Möller A., et al. “Changes in cytokine concentration during enrichment of early enteral nutrition with lactic acid bacterium (Synbiotic 2000) after major abdominal surgery”. Critical Care 1 (2004): P273.
41. Yokoyama Y., et al. “Effects of synbiotics to prevent postoperative infectious complications in highly invasive abdominal surgery”. Annals of Nutrition and Metabolism 1 (2017): 23-30.
42. Kim H., et al. “An unusual case of acute cholecystitis caused by Lactobacillus paracasei”. Cureus6 (2023): e40334.
43. Zhao JW., et al. “Fecal microbiota transplantation as potential first-line treatment for patients with Clostridioides difficile infection and prior appendectomy”. World Journal of Gastrointestinal Surgery 2 (2023): 303-306.
44. Peery AF., et al. “AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases”. Gastroenterology3 (2024): 409-434.